ARCHIVES

FDA: Silicone Breast Implants Safe, But Not “Lifetime Device”

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Study Links Breast, Pancreatic Cancer Risks to Lynch Syndrome

February 24, 2012

Mammography Reports Complete; Breast Project to Continue

March 25, 1977

Funding Opportunities: AACR Accepting Submissions for Two Dream Team Grants

September 19, 2014

NTP Board Gives Concept Approvals

December 4, 1981

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003